unmet medical need is clearly evident and is anticipated to augment the ventricular assist device market .
North America Ventricular Assist Device Market : Scope of the Study
This report on the ventricular assist device market in the North America analyzes the current and future prospects of the market . Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section . Market revenue in terms of US $ Mn for the period between 2014 and 2024 along with the compound annual growth rate ( CAGR %) from 2014 to 2024 are provided for all the segments , considering 2015 as the base year . Market related factors such as technological developments , patent expiry , recent approvals , investment in clinical studies and acquisitions by leading players in the market , and historical year-on-year growth have been taken into consideration while estimating the market size . Growth rates for each segment within the North America ventricular assist device market have been determined after a thorough analysis of past trends , demographics , future trends , technological developments , drug development life cycle , and regulatory requirements . These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the ventricular assist device market in North America .
North America Ventricular Assist Device Market : Segmentation
Based on product type , the North America ventricular assist device market has been segmented into Left Ventricular Assist Device ( LVAD ), Right Ventricular Assist Device ( RVAD ), Biventricular Assist Device ( Bi-VAD ) and total artificial heart ( TAH ).
Based on indication , the North America ventricular assist device market has been segmented into bridge to transplant ( BTT ), destination therapy ( DT ) and bridge to